Varex Imaging Corporation's stock plummeted 22.30% intraday on Friday, following the company's earnings call where it revised down its revenue guidance for the second quarter of fiscal 2025.
The medical imaging technology company cited supply chain challenges and labor shortages during the holiday period as the primary reasons for the lowered outlook. Unscheduled absences at its US facilities prevented Varex from fulfilling all product demand in the first quarter, leading to a revenue miss of around $5 million.
While demand remained solid, particularly in the industrial segment driven by cargo inspection systems, the company was unable to complete and ship a few orders worth millions of dollars due to production constraints. These orders are expected to be delivered in the second quarter, but the impact has led Varex to revise its revenue guidance down to the range of $200 million to $215 million for the current quarter.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.